Does the media prefer MMED or ESTA?

In the previous week, MiniMed Group had 2 more articles in the media than Establishment Labs. MarketBeat recorded 8 mentions for MiniMed Group and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.44 beat MiniMed Group's score of 0.78 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ESTA or TFX?

In the previous week, Teleflex had 4 more articles in the media than Establishment Labs. MarketBeat recorded 10 mentions for Teleflex and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.44 beat Teleflex's score of 0.48 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 2 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer HAE or ESTA?

In the previous week, Establishment Labs had 1 more articles in the media than Haemonetics. MarketBeat recorded 6 mentions for Establishment Labs and 5 mentions for Haemonetics. Establishment Labs' average media sentiment score of 1.44 beat Haemonetics' score of 0.83 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LIVN or ESTA?

In the previous week, Establishment Labs had 1 more articles in the media than LivaNova. MarketBeat recorded 6 mentions for Establishment Labs and 5 mentions for LivaNova. Establishment Labs' average media sentiment score of 1.44 beat LivaNova's score of 0.47 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Establishment Labs 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, ESTA or ITGR?

Integer has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Establishment Labs $211.08M 10.08 -$51.06M -$1.31 N/A Integer $1.85B 2.31 $102.81M $3.66 34.45

Is ESTA or ITGR more profitable?

Integer has a net margin of 6.97% compared to Establishment Labs' net margin of -15.82%. Integer's return on equity of 12.79% beat Establishment Labs' return on equity. Company Net Margins Return on Equity Return on Assets Establishment Labs -15.82% -196.69% -10.73% Integer 6.97% 12.79% 6.48%

Does the media refer more to ESTA or ITGR?

In the previous week, Establishment Labs had 2 more articles in the media than Integer. MarketBeat recorded 6 mentions for Establishment Labs and 4 mentions for Integer. Establishment Labs' average media sentiment score of 1.44 beat Integer's score of 0.35 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Establishment Labs (ESTA) Competitors

$71.39 -3.12 (-4.19%)

Closing price 04:00 PM Eastern

Extended Trading

$72.00 +0.61 (+0.85%)

As of 05:10 PM Eastern

Compare

ESTA vs. MMED, TFX, HAE, LIVN, and ITGR

Should you buy Establishment Labs stock or one of its competitors? Establishment Labs's main competitors and comparable companies include MiniMed Group (MMED), Teleflex (TFX), Haemonetics (HAE), LivaNova (LIVN), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Establishment Labs compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Establishment Labs (NASDAQ:ESTA) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

In the previous week, MiniMed Group had 2 more articles in the media than Establishment Labs. MarketBeat recorded 8 mentions for MiniMed Group and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.44 beat MiniMed Group's score of 0.78 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Establishment Labs has lower revenue, but higher earnings than MiniMed Group. Establishment Labs is trading at a lower price-to-earnings ratio than MiniMed Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	2.04	-$333M	-$0.68	N/A
Establishment Labs	$211.08M	10.08	-$51.06M	-$1.31	N/A

MiniMed Group currently has a consensus price target of $23.77, suggesting a potential upside of 5.92%. Establishment Labs has a consensus price target of $100.25, suggesting a potential upside of 40.43%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Establishment Labs is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

MiniMed Group has a net margin of 0.00% compared to Establishment Labs' net margin of -15.82%. MiniMed Group's return on equity of 0.00% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Establishment Labs	-15.82%	-196.69%	-10.73%

72.9% of Establishment Labs shares are owned by institutional investors. 0.0% of MiniMed Group shares are owned by company insiders. Comparatively, 10.0% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

MiniMed Group beats Establishment Labs on 8 of the 15 factors compared between the two stocks.

How does Establishment Labs compare to Teleflex?

Establishment Labs (NASDAQ:ESTA) and Teleflex (NYSE:TFX) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Establishment Labs has higher earnings, but lower revenue than Teleflex. Establishment Labs is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.08	-$51.06M	-$1.31	N/A
Teleflex	$1.99B	2.81	-$905.64M	-$23.29	N/A

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by company insiders. Comparatively, 0.7% of Teleflex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Establishment Labs has a net margin of -15.82% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
Teleflex	-39.67%	11.93%	5.44%

In the previous week, Teleflex had 4 more articles in the media than Establishment Labs. MarketBeat recorded 10 mentions for Teleflex and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.44 beat Teleflex's score of 0.48 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	2 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Establishment Labs has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Establishment Labs presently has a consensus price target of $100.25, indicating a potential upside of 40.43%. Teleflex has a consensus price target of $152.90, indicating a potential upside of 15.67%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
Teleflex	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Summary

Establishment Labs beats Teleflex on 10 of the 17 factors compared between the two stocks.

How does Establishment Labs compare to Haemonetics?

Haemonetics (NYSE:HAE) and Establishment Labs (NASDAQ:ESTA) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

Haemonetics currently has a consensus price target of $99.78, indicating a potential downside of 1.52%. Establishment Labs has a consensus price target of $100.25, indicating a potential upside of 40.43%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts plainly believe Establishment Labs is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

Haemonetics has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market.

Haemonetics has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	3.46	$97.31M	$2.04	49.66
Establishment Labs	$211.08M	10.08	-$51.06M	-$1.31	N/A

Haemonetics has a net margin of 7.12% compared to Establishment Labs' net margin of -15.82%. Haemonetics' return on equity of 27.55% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
Establishment Labs	-15.82%	-196.69%	-10.73%

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 2.1% of Haemonetics shares are held by company insiders. Comparatively, 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Establishment Labs had 1 more articles in the media than Haemonetics. MarketBeat recorded 6 mentions for Establishment Labs and 5 mentions for Haemonetics. Establishment Labs' average media sentiment score of 1.44 beat Haemonetics' score of 0.83 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Haemonetics beats Establishment Labs on 9 of the 17 factors compared between the two stocks.

How does Establishment Labs compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Establishment Labs (NASDAQ:ESTA) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

In the previous week, Establishment Labs had 1 more articles in the media than LivaNova. MarketBeat recorded 6 mentions for Establishment Labs and 5 mentions for LivaNova. Establishment Labs' average media sentiment score of 1.44 beat LivaNova's score of 0.47 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Establishment Labs	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova has a net margin of 12.82% compared to Establishment Labs' net margin of -15.82%. LivaNova's return on equity of 16.35% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	12.82%	16.35%	7.76%
Establishment Labs	-15.82%	-196.69%	-10.73%

Establishment Labs has lower revenue, but higher earnings than LivaNova. Establishment Labs is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.10	-$242.47M	$3.38	23.13
Establishment Labs	$211.08M	10.08	-$51.06M	-$1.31	N/A

LivaNova has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market.

LivaNova presently has a consensus target price of $84.13, suggesting a potential upside of 7.60%. Establishment Labs has a consensus target price of $100.25, suggesting a potential upside of 40.43%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts clearly believe Establishment Labs is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

97.6% of LivaNova shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 10.0% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Establishment Labs beats LivaNova on 9 of the 16 factors compared between the two stocks.

How does Establishment Labs compare to Integer?

Establishment Labs (NASDAQ:ESTA) and Integer (NYSE:ITGR) are both mid-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Integer has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.08	-$51.06M	-$1.31	N/A
Integer	$1.85B	2.31	$102.81M	$3.66	34.45

In the previous week, Establishment Labs had 2 more articles in the media than Integer. MarketBeat recorded 6 mentions for Establishment Labs and 4 mentions for Integer. Establishment Labs' average media sentiment score of 1.44 beat Integer's score of 0.35 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has a net margin of 6.97% compared to Establishment Labs' net margin of -15.82%. Integer's return on equity of 12.79% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
Integer	6.97%	12.79%	6.48%

Establishment Labs presently has a consensus price target of $100.25, indicating a potential upside of 40.43%. Integer has a consensus price target of $109.86, indicating a potential downside of 12.88%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Establishment Labs is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Establishment Labs has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market. Comparatively, Integer has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Summary

Establishment Labs and Integer tied by winning 8 of the 16 factors compared between the two stocks.

Get Establishment Labs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ESTA vs. The Competition

Export

Metric	Establishment Labs	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.13B	$5.40B	$7.12B	$12.70B
Dividend Yield	N/A	1.78%	2.55%	9.16%
P/E Ratio	-54.50	24.68	273.41	25.12
Price / Sales	10.08	72.46	670.91	117.13
Price / Cash	N/A	32.78	77.55	52.32
Price / Book	88.14	5.89	10.43	6.18
Net Income	-$51.06M	$150.94M	$3.49B	$358.18M
7 Day Performance	-1.26%	-2.92%	-2.99%	-2.34%
1 Month Performance	-4.89%	-3.20%	0.02%	-2.50%
1 Year Performance	88.22%	7.93%	20.19%	9.87%

Establishment Labs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ESTA Establishment Labs	3.8622 of 5 stars	$71.39 -4.2%	$100.25 +40.4%	+90.0%	$2.13B	$211.08M	N/A	1,004	Gap Down
MMED MiniMed Group	1.4319 of 5 stars	$22.93 -1.5%	$23.77 +3.6%	N/A	$6.45B	$3.10B	N/A	2,800	Gap Up
TFX Teleflex	3.7505 of 5 stars	$136.81 -1.1%	$152.90 +11.8%	+4.3%	$5.79B	$1.99B	N/A	15,500
HAE Haemonetics	1.7834 of 5 stars	$102.71 -0.2%	$99.78 -2.9%	+90.3%	$4.67B	$1.33B	50.29	3,009	Positive News
LIVN LivaNova	2.5482 of 5 stars	$81.01 -1.1%	$84.13 +3.9%	+34.4%	$4.45B	$1.39B	23.91	3,300	News Coverage Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ESTA) was last updated on 9/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Establishment Labs (ESTA) Competitors

ESTA vs. MMED, TFX, HAE, LIVN, and ITGR

How does Establishment Labs compare to MiniMed Group?

Summary

How does Establishment Labs compare to Teleflex?

Summary

How does Establishment Labs compare to Haemonetics?

Summary

How does Establishment Labs compare to LivaNova?

Summary

How does Establishment Labs compare to Integer?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Establishment Labs (ESTA) Competitors

ESTA vs. MMED, TFX, HAE, LIVN, and ITGR

How does Establishment Labs compare to MiniMed Group?

Does the media prefer MMED or ESTA?

Which has higher valuation & earnings, MMED or ESTA?

Do analysts prefer MMED or ESTA?

Is MMED or ESTA more profitable?

Do insiders and institutionals hold more shares of MMED or ESTA?

Summary

How does Establishment Labs compare to Teleflex?

Which has better valuation and earnings, ESTA or TFX?

Do institutionals & insiders have more ownership in ESTA or TFX?

Is ESTA or TFX more profitable?

Does the media refer more to ESTA or TFX?

Which has more volatility & risk, ESTA or TFX?

Do analysts prefer ESTA or TFX?

Summary

How does Establishment Labs compare to Haemonetics?

Do analysts rate HAE or ESTA?

Which has more risk and volatility, HAE or ESTA?

Which has better valuation & earnings, HAE or ESTA?

Is HAE or ESTA more profitable?

Do institutionals and insiders hold more shares of HAE or ESTA?

Does the media prefer HAE or ESTA?

Summary

How does Establishment Labs compare to LivaNova?

Does the media favor LIVN or ESTA?

Is LIVN or ESTA more profitable?

Which has stronger valuation and earnings, LIVN or ESTA?

Which has more risk and volatility, LIVN or ESTA?

Do analysts recommend LIVN or ESTA?

Do institutionals & insiders have more ownership in LIVN or ESTA?

Summary

How does Establishment Labs compare to Integer?

Which has stronger valuation & earnings, ESTA or ITGR?

Does the media refer more to ESTA or ITGR?

Is ESTA or ITGR more profitable?

Do analysts prefer ESTA or ITGR?

Do insiders & institutionals hold more shares of ESTA or ITGR?

Which has more volatility and risk, ESTA or ITGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools